RecruitingNCT06798181

Neuropathic Pain and Type II Diabetic Patients

The Effect of Neuropathic Pain on Self-Care Ability and Quality of Life in Type II Diabetic Patients


Sponsor

Bilecik Seyh Edebali Universitesi

Enrollment

128 participants

Start Date

Dec 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Diabetes Mellitus (DM) is a common metabolic disease characterized by hyperglycemia resulting from insufficiency, deficiency or absence of the insulin hormone. Chronic hyperglycemia, secondary metabolic and microvascular changes resulting in diabetic neuropathy are among the most common complications encountered in DM patients. Diabetic neuropathy is called peripheral, autonomic or spinal depending on the region of involvement. Peripheral involvement is more common than other region involvement and its prevalence in DM patients is observed to be 16-87%. Diabetic peripheral neuropathy (DPN) presents with numbness, tingling, paresthesia, muscle weakness and pain. These symptoms can start from the toes and progress to the leg and even the upper extremities. In diabetic peripheral neuropathy, pain is seen as burning, electric shock or sharp cold pain, increases at night and affects sleep quality. In these patients, daily living activities such as walking, climbing stairs, and sleeping are negatively affected by progressive DPN and pain, falls are observed, mood disorders are experienced, and the quality of life decreases.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria6

  • years and older,
  • Diagnosed with type II diabetes,
  • Reading and writing,
  • No physical or psychological communication barriers,
  • Can read and speak Turkish,
  • Volunteers

Exclusion Criteria1

  • Diagnosed with type I diabetes

Locations(1)

Bilecik Seyh Edeabli University

Bilecik, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06798181


Related Trials